Blood loss or anemia can lead to chronic health problems; therefore, clinicians performs blood transfusion that can help to get relief from chronic health problems. To transfuse, blood clinicians or hospitals take blood units present in their own integrated blood banks or from other centers. Immunohematology, also commonly known as blood banking, helps to screen the donor blood components for blood antigens, Rh factor, plasma, and white blood cell components. It helps to reduce blood transfusion-related diseases such as HIV and thalassemia. According to the guidelines by World Health Organization (WHO), donated blood is screened before it is transfused to protect the people from such fatalities in most of the countries.
Technavio’s analysts forecast the global immunohematology market to grow at a CAGR of 4.79% during the period 2016-2020.
Covered in this report The report covers the present scenario and the growth prospects of the global immunohematology market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various immunohematology analyzers, systems, and reagents, which are used for transfusion medicine in blood banks and hospitals to screen the blood for molecular typing and serological test.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Technavio's report, Global Immunohematology Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
Other prominent vendors - Agena Bioscience - BD - Beckman Coulter - biosurfit SA - Cardinal Health - DIAGAST - Hemo bioscience - Institut de Biotechnologies Jacques Boy - Lorne Laboratories - MTC INVITRO - Reagens - Seqirus - Tulip - Quotient
Market driver - Growing demand for blood banks and its potential to increase sales - For a full, detailed list, view our report
Market challenge - High maintenance cost and less reimbursement of blood components - For a full, detailed list, view our report
Market trend - Paradigm shift toward molecular immunohematology - For a full, detailed list, view our report
Key questions answered in this report - What will the market size be in 2020 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Our reports have been used by over 10K customers, including:
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines. Various vaccines have...
Over the past decade, pharmaceutical companies have pushed the scientific envelope, working at the cellular and molecular levels to dramatically advance the treatment of disease. The US pharmaceutical industry is a highly globalized industry, dominated by multinational companies that engage in significant business activity in many countries...
"Global Cancer Vaccine Market & Clinical Trial Insight 2025" Report Highlight: • Global Cancer Vaccine market Opportunity: US$ 15 Billion Opportunity • Personalized Cancer Vaccine: The Next growth Frontier • Global Cancer Vaccine Clinical insight by Indication & Phase of Development • Global Cancer...
The Global Infectious Vaccines Partnering Terms and Agreements 2012 to 2018: Deal trends, players and financials report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right...
This report forecasts for 2018 through 2024 global demand for human vaccines by pediatric and adult product groups in nominal US dollars at the manufacturer level. Global demand for pediatric vaccines is segmented in terms of: pneumococcal; combination; measles, mumps, and rubella; varicella; and other pediatric vaccines...
177 pages •
By Persistence Market Research
• Aug 2018
This report examines the ‘Global RNA-based Therapeutics and Vaccines Market for the period 2019–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global RNA-based Therapeutics and Vaccines Market. The RNA-based Therapeutics and Vaccines Market is Segmented as...